Landis contemplates Tour de France return

Landis Tour 4

Floyd Landis has stated that he is contemplating a return to the Tour de France in 2010. The American rider won the event in 2006 but was subsequently stripped of the title when he tested positive for synthetic testosterone during the race.

During an interview with the Reuters news agency published today, Landis said "I will take a few weeks of peace and quiet to assess what I want to do with the next years of my life.

"If I went back to the Tour de France the objective would be to win it again. And the objective would be for the resulting win to give me some time to enjoy it rather than the way it played out last time."

But Landis has seen Armstrong's successful comeback from retirement and obviously wants a piece of the action for himself.

And then there's the issue of whether he can get signed to a major team that gets selected for the event - again, doubtful given his high-profile positive drug test and the subsequent implosion of his 2006 team, Phonak as a result.

Finally, there's whether he can get fit enough to be competitive at the Tour, particularly given he has suffered on-going degenerative problems with his hips.

It's one thing to want to ride the Tour; it's another for the Tour to want you to ride it.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Former Associate Editor

Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.